Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.
Made up of two business units, Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology & our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
Lichtstrasse 35, 4002 Basel – Switzerland
|Date||Trading entity / Person||Association||Trade type||Volume|
|12.06.23||None||Executive member||Sell||CHF 260,113.56|
|16.05.23||None||Executive member||Sell||CHF 1,200,359.19|
|23.05.22||None||Executive member||Sell||CHF 84,085.12|
|27.04.22||None||Executive member||Sell||CHF 1,765,600.80|
|04.03.22||None||Non-Executive member||Buy||CHF 195,000.00|
|04.03.22||None||Non-Executive member||Buy||CHF 180,000.00|
|28.02.22||None||Executive member||Sell||CHF 80,880.00|
|25.02.22||None||Executive member||Sell||CHF 16,076.00|
|22.02.22||None||Executive member||Sell||CHF 47,451.25|
|21.02.22||None||Executive member||Sell||CHF 1.00|
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.